Literature DB >> 24899173

MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Yu-Jin Jung1, Hoyun Choi1, Hyoji Kim1, Suk Kyeong Lee2.   

Abstract

UNLABELLED: Epstein-Barr virus (EBV) is a human herpesvirus associated with various tumors. Rather than going through the lytic cycle, EBV maintains latency by limiting the expression of viral genes in tumors. Viral microRNAs (miRNAs) of some herpesviruses have been reported to directly target immediate early genes and suppress lytic induction. In this study, we investigated whether BamHI-A rightward transcript (BART) miRNAs targeted two EBV immediate early genes, BZLF1 and BRLF1. Bioinformatic analysis predicted that 12 different BART miRNAs would target BRLF1. Of these, the results of a luciferase reporter assay indicated that only one interacted with the 3' untranslated region (UTR) of BRLF1: miR-BART20-5p. miR-BART20-5p's effect on gene expression involved two putative seed match sites in the BRLF1 3' UTR, but a mutant version of the miRNA, miR-BART20-5pm, had no effect on expression. As expected from the fact that the entire 3' UTR of BZLF1 resides within the 3' UTR of BRLF1, miR-BART20-5p interacted with the 3' UTR of BZLF1 as well. BZLF1 and BRLF1 mRNA and protein expression was suppressed in cells of an AGS cell line infected with the recombinant Akata strain of EBV (AGS-EBV) transfected with a miR-BART20-5p mimic. The expression of various EBV early proteins was also suppressed by the miR-BART20-5p mimic. In contrast, BZLF1 and BRLF1 expression in AGS-EBV cells transfected with a miR-BART20-5p inhibitor was enhanced. Furthermore, progeny virus production was suppressed by the miR-BART20-5p mimic and enhanced by the miR-BART20-5p inhibitor in AGS-EBV cells induced for the lytic cycle. Our data suggest that miR-BART20-5p plays a key role in latency maintenance in EBV-associated tumors by directly targeting immediate early genes. IMPORTANCE: Herpesviruses maintain latency using various mechanisms and establish lifelong infection in the host. From time to time, herpesviruses are reactivated and express immediate early genes which trigger a lytic cascade, leading to the production of progeny viruses. Recently, some herpesviruses have been shown to use their own microRNAs (miRNAs) to downregulate immediate early genes to inhibit the lytic cycle. This study presents evidence that EBV also downregulates two immediate early genes by miR-BART20-5p to suppress the lytic cycle and progeny virus production. Overall, this is the first study to report the direct regulation of EBV immediate early genes by an EBV miRNA, implying its likely importance in latency maintenance in EBV-associated tumors.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24899173      PMCID: PMC4136301          DOI: 10.1128/JVI.00721-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  EBV encoded miR-BHRF1-1 potentiates viral lytic replication by downregulating host p53 in nasopharyngeal carcinoma.

Authors:  Zijian Li; Xue Chen; Lili Li; Sufang Liu; Lifang Yang; Xiaoqian Ma; Min Tang; Ann M Bode; Zigang Dong; Lunquan Sun; Ya Cao
Journal:  Int J Biochem Cell Biol       Date:  2011-11-17       Impact factor: 5.085

Review 2.  Viral miRNAs and immune evasion.

Authors:  Isaac W Boss; Rolf Renne
Journal:  Biochim Biophys Acta       Date:  2011-07-05

3.  EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-γ-STAT1 pathway associated with disease progression in nasal NK-cell lymphoma.

Authors:  Wei-Ting Huang; Chung-Wu Lin
Journal:  Am J Pathol       Date:  2014-04       Impact factor: 4.307

4.  Association between Epstein-Barr virus infection and chemoresistance to docetaxel in gastric carcinoma.

Authors:  Hee Jong Shin; Do Nyun Kim; Suk Kyeong Lee
Journal:  Mol Cells       Date:  2011-05-27       Impact factor: 5.034

Review 5.  Regulation of the latent-lytic switch in Epstein-Barr virus.

Authors:  Shannon C Kenney; Janet E Mertz
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

6.  Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil.

Authors:  Jung Seon Seo; Tai-Gyu Kim; Young Seon Hong; Jen-Yang Chen; Suk Kyeong Lee
Journal:  Arch Pharm Res       Date:  2011-05-05       Impact factor: 4.946

7.  Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.

Authors:  Qin Yan; Xinting Ma; Chenyou Shen; Xu Cao; Ninghan Feng; Di Qin; Yi Zeng; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

8.  Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation with secondary suppression of p53 in invasive nasal NK/T-cell lymphoma.

Authors:  Ting-Chu Lin; Ting-Yun Liu; Su-Ming Hsu; Chung-Wu Lin
Journal:  Am J Pathol       Date:  2013-05       Impact factor: 4.307

9.  Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1.

Authors:  Do Nyun Kim; Min Koo Seo; Hoyun Choi; Su Yeon Kim; Hee Jong Shin; A-Ran Yoon; Qian Tao; Sun Young Rha; Suk Kyeong Lee
Journal:  J Gen Virol       Date:  2012-11-21       Impact factor: 3.891

10.  Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells.

Authors:  Aron R Marquitz; Anuja Mathur; Pauline E Chugh; Dirk P Dittmer; Nancy Raab-Traub
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

View more
  49 in total

Review 1.  EBV Noncoding RNAs.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 2.  Herpesvirus microRNAs for use in gene therapy immune-evasion strategies.

Authors:  S T F Bots; R C Hoeben
Journal:  Gene Ther       Date:  2017-05-09       Impact factor: 5.250

3.  Pigmy MicroRNA: surveillance cops in Therapies kingdom.

Authors:  Utpal Bhadra; Pradipta Patra; Jagamohan Chhatai; Manika Pal-Bhadra
Journal:  Mol Med       Date:  2016-09-28       Impact factor: 6.354

Review 4.  Herpesvirus latency.

Authors:  Jeffrey I Cohen
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

5.  Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer.

Authors:  Jia Wang; Xiang Zheng; Zailong Qin; Lingyu Wei; Yuanjun Lu; Qiu Peng; Yingxue Gao; Xuemei Zhang; Xiaoyue Zhang; Zhengshuo Li; Yuxin Fu; Peishan Liu; Can Liu; Qun Yan; Wei Xiong; Guiyuan Li; Jianhong Lu; Jian Ma
Journal:  J Biol Chem       Date:  2019-01-23       Impact factor: 5.157

6.  A human herpesvirus 6A-encoded microRNA: role in viral lytic replication.

Authors:  Masatoshi Nukui; Yasuko Mori; Eain A Murphy
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

Review 7.  Epigenetics and Genetics of Viral Latency.

Authors:  Paul M Lieberman
Journal:  Cell Host Microbe       Date:  2016-05-11       Impact factor: 21.023

8.  Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing.

Authors:  Lijuan Hu; Zhirui Lin; Yanheng Wu; Juqin Dong; Bo Zhao; Yanbing Cheng; Peiyu Huang; Lihua Xu; Tianliang Xia; Dan Xiong; Hongbo Wang; Manzhi Li; Ling Guo; Elliott Kieff; Yixin Zeng; Qian Zhong; Musheng Zeng
Journal:  Front Med       Date:  2016-03-11       Impact factor: 4.592

Review 9.  Roles of Non-coding RNAs During Herpesvirus Infection.

Authors:  Meaghan H Hancock; Rebecca L Skalsky
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

10.  Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.

Authors:  Xiang Zheng; Jia Wang; Lingyu Wei; Qiu Peng; Yingxue Gao; Yuxin Fu; Yuanjun Lu; Zailong Qin; Xuemei Zhang; Jianhong Lu; Chunlin Ou; Zhengshuo Li; Xiaoyue Zhang; Peishan Liu; Wei Xiong; Guiyuan Li; Qun Yan; Jian Ma
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.